Top Markets
#1 Black Phoenix Black Phoenix +166.50%
#2 Islamic Coin Islamic Coin +158.23%
#3 Glidr Glidr +58.56%
#4 Cryptopia Cryptopia +20.42%
#5 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.07%
#6 DOVU DOVU +16.19%
#7 Wrapped Bitcoin (PulseChain) Wrapped Bitcoin (PulseChain) +11.09%
#8 MarsCoin MarsCoin +10.39%
#9 stake.link stake.link +8.68%
#10 Useless Coin Useless Coin +7.42%
Coin of the day
Black Phoenix Black Phoenix
Innstillinger
Språk
NORSK
Valuta
USD
Tema
VIA Pharmaceuticals, Inc. VIA Pharmaceuticals, Inc.

VIA Pharmaceuticals, Inc.

VIAP
Rangering i aksjer #41780
VIA Pharmaceuticals, Inc. is an emerging biotechnology company primarily... VIA Pharmaceuticals, Inc. is an emerging biotechnology company primarily focused on discovering and advancing therapeutic compounds for cardiovascular and metabolic disorders. The firm is building a portfolio of small-molecule drug candidates designed to tackle the root causes of these health issues, such as vascular inflammation, elevated cholesterol and triglyceride levels, and insulin resistance or diabetes. Notable candidates in their development pipeline include: VIA-3196: A liver-specific thyroid hormone receptor (THR) beta agonist, poised for Phase 1 clinical studies. This drug aims to mitigate dyslipidemia, addressing high LDL cholesterol, elevated triglycerides, and Lp(a) levels. A Diacylglycerol Acyl Transferase 1 (DGAT1) inhibitor: Currently in preclinical development for treating type 2 diabetes, with promising potential for weight management and other lipid disorders. VIA-2291: A 5-Lipoxygenase inhibitor that has successfully completed its third Phase 2 clinical trial. Its purpose is to target atherosclerotic plaque, a significant contributor to heart attacks, strokes, and various other vascular diseases. VIA Pharmaceuticals has also forged two research, development, and commercialization agreements with Hoffman-LaRoche Inc. and Hoffman-LaRoche Ltd. These collaborations pertain to their THR beta agonist program and several compounds from their preclinical DGAT1 metabolic disorders initiative. Established in 2004, the company's headquarters are located in San Francisco, California.
Aksjekurs
$0.0005
Sist synkronisert: 2026-08-11
Markedsverdi
$10.28K
Endring (1 dag)
0.00%
Endring (1 år)
0.00%
Land
US
Handel VIA Pharmaceuticals, Inc. (VIAP)

Kategori

Healthcare
Pris VIAP pris med markedsverdi på B
VIA Pharmaceuticals, Inc. VIA Pharmaceuticals, Inc.
VIAP
$0.0005
Markedsverdi av VIA Pharmaceuticals, Inc.(VIAP)
Markedsverdi: $10.28K
Per August 2026 har VIA Pharmaceuticals, Inc. en markedsverdi på $10.28K. Dette gjør VIA Pharmaceuticals, Inc. til det 41780th mest verdifulle selskapet i verden basert på markedsverdi ifølge våre data. Markedsverdi er den totale markedsverdien av et børsnotert selskaps utestående aksjer og brukes vanligvis til å måle hvor mye et selskap er verdt.
Markedsverdihistorikk for VIA Pharmaceuticals, Inc. fra 2007 til 2026
VIAP sammenlignet med topp 5 mest populære stocks
Pris på VIAP Eiendel B Markedsverdi for B Resultater
VIA Pharmaceuticals, Inc. VIA Pharmaceuticals, Inc.
$261,862 $10.28K
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.383T +52,372,404,414.06%
VIA Pharmaceuticals, Inc. VIA Pharmaceuticals, Inc.
$215,166 $10.28K
Apple Inc. Apple Inc.
AAPL
$4.423T +43,033,283,329.69%
VIA Pharmaceuticals, Inc. VIA Pharmaceuticals, Inc.
$202,372 $10.28K
Alphabet Inc. Alphabet Inc.
GOOG
$4.160T +40,474,456,550.28%
VIA Pharmaceuticals, Inc. VIA Pharmaceuticals, Inc.
$178,194 $10.28K
Microsoft Corporation Microsoft Corporation
MSFT
$3.663T +35,638,883,419.80%
VIA Pharmaceuticals, Inc. VIA Pharmaceuticals, Inc.
$140,638 $10.28K
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.891T +28,127,529,770.61%